Inflammatix Gets FDA Clearance for Sepsis and Acute Infection Test
Inflammatix’s test system provides accurate infection likelihood and illness severity assessments for sepsis and acute infections.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Sepsis |
Inflammatix’s test system provides accurate infection likelihood and illness severity assessments for sepsis and acute infections.
Read MorePosted by Andy Lundin | Jan 16, 2025 | Lymphoma, Molecular Diagnostics |
Foresight Diagnostics’ ctDNA-MRD testing has been included in the NCCN Clinical Practice Guidelines for diffuse large B-cell lymphoma.
Read MorePosted by Andy Lundin | Jan 14, 2025 | Allergy & Autoimmune, Immunoassay Reagents & test Kits |
Werfen’s Aptiva APS IgG and IgM Reagents for antiphospholipid syndrome (APS) diagnosis address a need in autoimmune disease diagnostics.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Diagnostic Technologies, Sepsis |
The procalcitonin biomarker to guide antibiotic treatment in hospitalized children does not shorten intravenous antibiotic duration compared.
Read MorePosted by Andy Lundin | Jan 6, 2025 | Accreditation |
2024 CAP Laboratory Accreditation Program checklists integrate key CLIA final rule changes, revised personnel requirements, and more.
Read More